SEARCH

SEARCH BY CITATION

References

  • 1
    Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 22122219.
  • 2
    Centers for Disease Control and Prevention, Division of Viral Hepatitis. Hepatitis B information for health professionals: statistics and surveillance. http://www.cdc.gov/hepatitis/HBV/StatisticsHBV.htm. Accessed September 27, 2012.
  • 3
    Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661662.
  • 4
    Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis 2012; 32: 211219.
  • 5
    Gheorghe L, Iacob S, Simionov I, Vadan R, Constantinescu I, Caruntu F, et al. Weight-based dosing regimen of peg-interferon alpha-2b for chronic hepatitis delta: a multicenter Romanian trial. J Gastrointestin Liver Dis 2011; 20: 377382.
  • 6
    World Health Organization. HIV data and statistics. http://www.who.int/hiv/data/en/. Accessed November 28, 2012.
  • 7
    Gatanaga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S. Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis 2000; 19: 237239.
  • 8
    Merchante N, Merino E, Lopez-Aldeguer J, Jover F, Delgado-Fernandez M, Galindo MJ, et al. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013; 56: 143150.
  • 9
    Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A, et al; Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet 2002; 360: 19211926.
  • 10
    AIDSinfo. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. What's New in the Guidelines? http://www.aidsinfo.nih.gov/Guidelines/HTML/1/adult-and-adolescent-treatment-guidelines/0/. Accessed September 30, 2012.
  • 11
    European AIDS Clinical Society. European AIDS Clinical Society guidelines: version 6. Accessed September 30, 2012.
  • 12
    Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008; 6: 13151341; quiz 1286.
  • 13
    Klein MB, Baril JG, Charron MA, Fortin C, Lalonde R, Matte MF, et al. Management and treatment of hepatitis B virus in patients with HIV infection: a practical guide for health care professionals. Can J Infect Dis Med Microbiol 2011; 22: 8896.
  • 14
    Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009; 136: 496504.e3.